229 related articles for article (PubMed ID: 21346244)
1. CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.
Motyl KJ; Raetz M; Tekalur SA; Schwartz RC; McCabe LR
Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1250-60. PubMed ID: 21346244
[TBL] [Abstract][Full Text] [Related]
2. Caspase-2 deficiency protects mice from diabetes-induced marrow adiposity.
Coe LM; Lippner D; Perez GI; McCabe LR
J Cell Biochem; 2011 Sep; 112(9):2403-11. PubMed ID: 21538476
[TBL] [Abstract][Full Text] [Related]
3. 2,3,7,8-Tetrachlorodibenzo-p-dioxin dose-dependently increases bone mass and decreases marrow adiposity in juvenile mice.
Fader KA; Nault R; Raehtz S; McCabe LR; Zacharewski TR
Toxicol Appl Pharmacol; 2018 Jun; 348():85-98. PubMed ID: 29673856
[TBL] [Abstract][Full Text] [Related]
4. GPCR kinase 2 interacting protein 1 (GIT1) regulates osteoclast function and bone mass.
Menon P; Yin G; Smolock EM; Zuscik MJ; Yan C; Berk BC
J Cell Physiol; 2010 Nov; 225(3):777-85. PubMed ID: 20568227
[TBL] [Abstract][Full Text] [Related]
5. Both spontaneous Ins2(+/-) and streptozotocin-induced type I diabetes cause bone loss in young mice.
Coe LM; Zhang J; McCabe LR
J Cell Physiol; 2013 Apr; 228(4):689-95. PubMed ID: 22886636
[TBL] [Abstract][Full Text] [Related]
6. Deletion of FoxO1, 3, and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes.
Iyer S; Han L; Ambrogini E; Yavropoulou M; Fowlkes J; Manolagas SC; Almeida M
J Bone Miner Res; 2017 Jan; 32(1):60-69. PubMed ID: 27491024
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival.
Motyl KJ; McCauley LK; McCabe LR
J Cell Physiol; 2012 Apr; 227(4):1326-34. PubMed ID: 21604269
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss.
Botolin S; McCabe LR
J Cell Physiol; 2006 Dec; 209(3):967-76. PubMed ID: 16972249
[TBL] [Abstract][Full Text] [Related]
9. Role of parathyroid hormone-related protein in the decreased osteoblast function in diabetes-related osteopenia.
Lozano D; de Castro LF; Dapía S; Andrade-Zapata I; Manzarbeitia F; Alvarez-Arroyo MV; Gómez-Barrena E; Esbrit P
Endocrinology; 2009 May; 150(5):2027-35. PubMed ID: 19196804
[TBL] [Abstract][Full Text] [Related]
10. Defective thermoregulation, impaired lipid metabolism, but preserved adrenergic induction of gene expression in brown fat of mice lacking C/EBPbeta.
Carmona MC; Hondares E; Rodríguez de la Concepción ML; Rodríguez-Sureda V; Peinado-Onsurbe J; Poli V; Iglesias R; Villarroya F; Giralt M
Biochem J; 2005 Jul; 389(Pt 1):47-56. PubMed ID: 15762841
[TBL] [Abstract][Full Text] [Related]
11. Bone inflammation and altered gene expression with type I diabetes early onset.
Motyl KJ; Botolin S; Irwin R; Appledorn DM; Kadakia T; Amalfitano A; Schwartz RC; McCabe LR
J Cell Physiol; 2009 Mar; 218(3):575-83. PubMed ID: 19006181
[TBL] [Abstract][Full Text] [Related]
12. Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.
Botolin S; Faugere MC; Malluche H; Orth M; Meyer R; McCabe LR
Endocrinology; 2005 Aug; 146(8):3622-31. PubMed ID: 15905321
[TBL] [Abstract][Full Text] [Related]
13. The increase in bone resorption in early-stage type I diabetic mice is induced by RANKL secreted by increased bone marrow adipocytes.
Yang J; Chen S; Zong Z; Yang L; Liu D; Bao Q; Du W
Biochem Biophys Res Commun; 2020 Apr; 525(2):433-439. PubMed ID: 32102755
[TBL] [Abstract][Full Text] [Related]
14. CCAAT/enhancer-binding protein β expressed by bone marrow mesenchymal stromal cells regulates early B-cell lymphopoiesis.
Yoshioka S; Miura Y; Yao H; Satake S; Hayashi Y; Tamura A; Hishita T; Ichinohe T; Hirai H; Takaor-Kondo A; Maekawa T
Stem Cells; 2014 Mar; 32(3):730-40. PubMed ID: 24115241
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation.
Coe LM; Tekalur SA; Shu Y; Baumann MJ; McCabe LR
J Cell Physiol; 2015 Aug; 230(8):1944-53. PubMed ID: 25641511
[TBL] [Abstract][Full Text] [Related]
16. Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice.
Harrison JR; Huang YF; Wilson KA; Kelly PL; Adams DJ; Gronowicz GA; Clark SH
J Biol Chem; 2005 Mar; 280(9):8117-24. PubMed ID: 15598659
[TBL] [Abstract][Full Text] [Related]
17. CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice.
Schroeder-Gloeckler JM; Rahman SM; Janssen RC; Qiao L; Shao J; Roper M; Fischer SJ; Lowe E; Orlicky DJ; McManaman JL; Palmer C; Gitomer WL; Huang W; O'Doherty RM; Becker TC; Klemm DJ; Jensen DR; Pulawa LK; Eckel RH; Friedman JE
J Biol Chem; 2007 May; 282(21):15717-29. PubMed ID: 17387171
[TBL] [Abstract][Full Text] [Related]
18. PTHrP-Derived Peptides Restore Bone Mass and Strength in Diabetic Mice: Additive Effect of Mechanical Loading.
Maycas M; McAndrews KA; Sato AY; Pellegrini GG; Brown DM; Allen MR; Plotkin LI; Gortazar AR; Esbrit P; Bellido T
J Bone Miner Res; 2017 Mar; 32(3):486-497. PubMed ID: 27683064
[TBL] [Abstract][Full Text] [Related]
19. CCAAT/enhancer-binding protein β overexpression alleviates myocardial remodelling by regulating angiotensin-converting enzyme-2 expression in diabetes.
Tie Y; Zhai C; Zhang Y; Qin X; Yu F; Li H; Shan M; Zhang C
J Cell Mol Med; 2018 Mar; 22(3):1475-1488. PubMed ID: 29266779
[TBL] [Abstract][Full Text] [Related]
20. Deletion of phospholipase D1 decreases bone mass and increases fat mass via modulation of Runx2, β-catenin-osteoprotegerin, PPAR-γ and C/EBPα signaling axis.
Kang DW; Hwang WC; Noh YN; Che X; Lee SH; Jang Y; Choi KY; Choi JY; Min DS
Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166084. PubMed ID: 33497821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]